Advanced Enzyme Technologies informs about outcome of board meeting

02 Nov 2019 Evaluate

Advanced Enzyme Technologies has informed that the Board of Directors in its meeting held on November 02, 2019, has transacted approval of the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2019. Further, the Company enclosed Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30, 2019 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company as Annexure - I; and Earnings Presentation for the quarter and half year ended September 30, 2019.

The above information is a part of company’s filings submitted to BSE.

Advanced Enzyme Share Price

358.25 4.10 (1.16%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.